Brendan J Guercio

10PUBLICATIONS
83CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2026
Association between hyperphosphatemia and overall survival among patients with advanced urothelial cancer treated with erdafitinib in phase 2/3 clinical trials.

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|Nov 27, 2025
The Microbiome and Genitourinary Cancers: A New Frontier.

Timothy B Winslow, Sophia Gupta, Vedha Sai Vaddaraju

|Jul 01, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601.

Gopa Iyer, Woonyoung Choi, Bin Luo

|Oct 29, 2024
Novel metabolomic predictors of incident colorectal cancer in men and women.

Jonathan M Downie, Amit D Joshi, Connor M Geraghty

|Sep 08, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.

Brendan J Guercio, Michal Sarfaty, Min Yuen Teo

Pageof 2

Frequent Collaborators

3 joint publications

Jonathan E Rosenberg

3 joint publications

Ashley M Regazzi

3 joint publications

Jeffrey A Meyerhardt

3 joint publications

Gopa Iyer